CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Enzalutamide

恩扎卢胺 杂质对照品Enzalutamide Impurities

52 个杂质条目52 impurity entries

本页汇总 恩扎卢胺 的 52 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 52 impurity reference standards of Enzalutamide. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 恩扎卢胺(Enzalutamide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsQuality by design with design of experiments approach for development of a stability-indicating LC method for enzalutamide and its impurities in soft gel dosage formulation
    Biomedical chromatography : BMC · 2021 · Katakam LNR et al.  ·  PMID 33410554  ·  DOI
  2. 分析方法Analytical MethodsImpurity profiling and stability analysis of enzalutamide: Identification, genotoxicity assessment, and development of UHPLC methods for critical impurities
    Journal of pharmaceutical and biomedical analysis · 2025 · Oktar Uzun B et al.  ·  PMID 40311542  ·  DOI
  3. 分析方法Analytical MethodsQuantification of 2-aminoisobutyric acid impurity in enzalutamide bulk drug substance using hydrophilic interaction chromatography with fluorescence detection
    Journal of pharmaceutical and biomedical analysis · 2019 · Douša M  ·  PMID 30412802  ·  DOI
  4. 分析方法Analytical MethodsStructural elucidation of the impurities in Enzalutamide bulk drug and the development, validation of corresponding HPLC method
    Journal of pharmaceutical and biomedical analysis · 2016 · Ma X et al.  ·  PMID 27664386  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of Enantiospecific Androgen Receptor Antagonists of Enzalutamide-Resistant Human Prostate Cancer Cells
    ACS medicinal chemistry letters · 2026 · Liu C et al.  ·  PMID 42621436  ·  DOI

恩扎卢胺 —— 原料药与杂质对照品Enzalutamide — drug substance & impurities

共 53 个条目(含原料药本体)53 items incl. the drug substance
Enzalutamide structure
原料药 APIAPI
恩杂鲁胺Enzalutamide
Enzalutamide
CAS No.915087-33-1
Chemical FormulaC21H16F4N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 1 structure
1
恩扎卢胺杂质1Enzalutamide Impurity 1
Enzalutamide Impurity 1
CAS No.1242137-15-0
Chemical FormulaC20H13F4N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 2 structure
2
恩杂鲁胺杂质2Enzalutamide Impurity 2
Enzalutamide Impurity 2
CAS No.1242137-16-1
Chemical FormulaC20H14F4N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 3 structure
3
恩扎卢胺杂质3Enzalutamide Impurity 3
Enzalutamide Impurity 3
CAS No.1242137-18-3
Chemical FormulaC21H16F4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 4 structure
4
恩扎卢胺杂质4Enzalutamide Impurity 4
Enzalutamide Impurity 4
CAS No.1802242-47-2
Chemical FormulaC13H16FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 5 structure
5
恩扎卢胺杂质5Enzalutamide Impurity 5
Enzalutamide Impurity 5
CAS No.915087-16-0
Chemical FormulaC21H17F3N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 7 structure
7
恩扎卢胺杂质7Enzalutamide Impurity 7
Enzalutamide Impurity 7
CAS No.1802242-43-8
Chemical FormulaC21H15F4N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 10 structure
10
恩扎卢胺杂质10Enzalutamide Impurity 10
Enzalutamide Impurity 10
CAS No.1332524-02-3
Chemical FormulaC11H12FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 11 structure
11
恩扎卢胺杂质11Enzalutamide Impurity 11
Enzalutamide Impurity 11
CAS No.2030242-21-6
Chemical FormulaC21H18F4N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 12 structure
12
恩扎卢胺杂质12Enzalutamide Impurity 12
Enzalutamide Impurity 12
CAS No.1895865-11-8
Chemical FormulaC17H8F6N4O
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 13 structure
13
恩扎卢胺杂质13Enzalutamide Impurity 13
Enzalutamide Impurity 13
CAS No.112704-79-7
Chemical FormulaC7H4BrFO2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 14 structure
14
恩扎卢胺杂质14Enzalutamide Impurity 14
Enzalutamide Impurity 14
CAS No.749927-69-3
Chemical FormulaC8H7BrFNO
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 15 structure
15
恩扎卢胺杂质15Enzalutamide Impurity 15
Enzalutamide Impurity 15
CAS No.179232-29-2
Chemical FormulaC8H6BrFO2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 1-d6 structure
1-D6
恩扎卢胺杂质1-d6Enzalutamide Impurity 1-d6
Enzalutamide Impurity 1-d6
CAS No.2746238-00-4
Chemical FormulaC20H7D6F4N3O3S
Purity>95%询价On request
Enzalutamide Impurity 16 structure
16
恩扎卢胺杂质16Enzalutamide Impurity 16
Enzalutamide Impurity 16
CAS No.2810090-73-2
Chemical FormulaC30H18F6N6O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 17 structure
17
恩扎卢胺杂质17Enzalutamide Impurity 17
Enzalutamide Impurity 17
CAS No.1242137-17-2
Chemical FormulaC20H14F4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 19 structure
19
恩扎卢胺杂质19Enzalutamide Impurity 19
Enzalutamide Impurity 19
CAS No.915087-32-0
Chemical FormulaC12H14FN3O
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 20 structure
20
恩扎卢胺杂质20Enzalutamide Impurity 20
Enzalutamide Impurity 20
CAS No.915087-25-1
Chemical FormulaC8H9FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 21 structure
21
恩扎卢胺杂质21Enzalutamide Impurity 21
Enzalutamide Impurity 21
CAS No.143782-23-4
Chemical FormulaC9H3F3N2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 26 structure
26
恩扎卢胺杂质26Enzalutamide Impurity 26
Enzalutamide Impurity 26
CAS No.1289942-55-7
Chemical FormulaC20H18F4N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 27 structure
27
恩扎卢胺杂质27Enzalutamide Impurity 27
Enzalutamide Impurity 27
CAS No.3035510-40-5
Chemical FormulaC21H18F4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 28 structure
28
恩扎卢胺杂质28Enzalutamide Impurity 28
Enzalutamide Impurity 28
CAS No.1895865-10-7
Chemical FormulaC10H7F3N2OS
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 29 structure
29
恩扎卢胺杂质29Enzalutamide Impurity 29
Enzalutamide Impurity 29
CAS No.3035510-32-5
Chemical FormulaC28H16F7N5O2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 30 structure
30
恩扎卢胺杂质30Enzalutamide Impurity 30
Enzalutamide Impurity 30
CAS No.1242137-19-4
Chemical FormulaC20H15F4N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 31 structure
31
恩扎卢胺杂质31Enzalutamide Impurity 31
Enzalutamide Impurity 31
CAS No.2029195-97-7
Chemical FormulaC21H18F4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 32 structure
32
恩扎卢胺杂质32Enzalutamide Impurity 32
Enzalutamide Impurity 32
CAS No.1332524-01-2
Chemical FormulaC13H17FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 33 structure
33
恩扎卢胺杂质33Enzalutamide Impurity 33
Enzalutamide Impurity 33
CAS No.1289942-66-0
Chemical FormulaC12H15FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 36 structure
36
恩扎卢胺杂质36Enzalutamide Impurity 36
Enzalutamide Impurity 36
CAS No.208122-06-9
Chemical FormulaC9H7F3N2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 37 structure
37
恩扎卢胺杂质37Enzalutamide Impurity 37
Enzalutamide Impurity 37
CAS No.1784897-62-6
Chemical FormulaC8H6BrFO
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 38 structure
38
恩扎卢胺杂质38Enzalutamide Impurity 38
Enzalutamide Impurity 38
CAS No.2138465-19-5
Chemical FormulaC8H4BrF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 41 structure
41
恩扎卢胺杂质41Enzalutamide Impurity 41
Enzalutamide Impurity 41
CAS No.1805523-50-5
Chemical FormulaC9H5BrFNO2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 44 structure
44
恩扎卢胺杂质44Enzalutamide Impurity 44
Enzalutamide Impurity 44
CAS No.1802242-46-1
Chemical FormulaC12H14FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 46 structure
46
恩扎卢胺杂质46Enzalutamide Impurity 46
Enzalutamide Impurity 46
CAS No.2138465-20-8
Chemical FormulaC7H4BrF3O
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 47 structure
47
恩扎卢胺杂质47Enzalutamide Impurity 47
Enzalutamide Impurity 47
CAS No.1443331-78-9
Chemical FormulaC22H18F4N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 49 structure
49
恩扎卢胺杂质49Enzalutamide Impurity 49
Enzalutamide Impurity 49
CAS No.177960-04-2
Chemical FormulaC10H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 51 structure
51
恩扎卢胺杂质51Enzalutamide Impurity 51
Enzalutamide Impurity 51
CAS No.1895865-08-3
Chemical FormulaC16H10F3N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 54 structure
54
恩扎卢胺杂质54Enzalutamide Impurity 54
Enzalutamide Impurity 54
CAS No.24115-24-0
Chemical FormulaC7H4Br2F3N
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 55 structure
55
恩扎卢胺杂质55Enzalutamide Impurity 55
Enzalutamide Impurity 55
CAS No.1806296-18-3
Chemical FormulaC7H4Br2F3N
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 56 structure
56
恩扎卢胺杂质56Enzalutamide Impurity 56
Enzalutamide Impurity 56
CAS No.2088914-60-5
Chemical FormulaC12H11F3N2OS
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 57 structure
57
恩扎卢胺杂质57Enzalutamide Impurity 57
Enzalutamide Impurity 57
CAS No.1242137-20-7
Chemical FormulaC11H13FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 58 structure
58
恩扎卢胺杂质58Enzalutamide Impurity 58
Enzalutamide Impurity 58
CAS No.749927-80-8
Chemical FormulaC9H9BrFNO
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 70 structure
70
恩扎卢胺杂质70Enzalutamide Impurity 70
Enzalutamide Impurity 70
CAS No.1798807-39-2
Chemical FormulaC17H12F4N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 71 structure
71
恩扎卢胺杂质71Enzalutamide Impurity 71
Enzalutamide Impurity 71
CAS No.1802242-44-9
Chemical FormulaC22H17F4N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 72 structure
72
恩扎卢胺杂质72Enzalutamide Impurity 72
Enzalutamide Impurity 72
CAS No.2463603-98-5
Chemical FormulaC21H19F4N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 74 structure
74
恩扎卢胺杂质74Enzalutamide Impurity 74
Enzalutamide Impurity 74
CAS No.2413534-37-7
Chemical FormulaC20H23FN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 77 structure
77
恩扎卢胺杂质77Enzalutamide Impurity 77
Enzalutamide Impurity 77
CAS No.2525176-29-6
Chemical FormulaC21H15BrF4N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 79 structure
79
恩扎卢胺杂质79Enzalutamide Impurity 79
Enzalutamide Impurity 79
CAS No.392-09-6
Chemical FormulaC8H6FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 81 structure
81
恩扎卢胺杂质81Enzalutamide Impurity 81
Enzalutamide Impurity 81
CAS No.3079438-61-9
Chemical FormulaC9H3F3N2S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 82 structure
82
恩扎卢胺杂质82Enzalutamide Impurity 82
Enzalutamide Impurity 82
CAS No.948294-47-1
Chemical FormulaC8H3BrF3NS
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 84 structure
84
恩扎卢胺杂质84Enzalutamide Impurity 84
Enzalutamide Impurity 84
CAS No.1803786-53-9
Chemical FormulaC7H4Br2F3N
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 86 structure
86
恩扎卢胺杂质86Enzalutamide Impurity 86
Enzalutamide Impurity 86
CAS No.1795013-81-8
Chemical FormulaC21H16F4N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 87 structure
87
恩扎卢胺杂质87Enzalutamide Impurity 87
Enzalutamide Impurity 87
CAS No.261951-85-3
Chemical FormulaC7H3BrF4
Purity>95%询价On request
10mg25mg50mg100mg
Enzalutamide Impurity 89 structure
89
恩扎卢胺杂质89Enzalutamide Impurity 89
Enzalutamide Impurity 89
CAS No.888072-96-6
Chemical FormulaC9H4F3N3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

恩扎卢胺 —— 研究文献与合成路线Enzalutamide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 恩扎卢胺 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Enzalutamide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Quality by design with design of experiments approach for development of a stability-indicating LC method for enzalutamide and its impurities in soft gel dosage formulation
    Katakam LNR, Dongala T, Ettaboina SK · Biomedical chromatography : BMC · 2021 · 被引 14cited 14
  2. Impurity profiling and stability analysis of enzalutamide: Identification, genotoxicity assessment, and development of UHPLC methods for critical impurities
    Oktar Uzun B, Kaygu P, Keskin E, et al. · Journal of pharmaceutical and biomedical analysis · 2025 · 被引 1cited 1
  3. Quantification of Newly Discovered Anti-Cancer Drug Enzalutamide in Bulk and Synthetic Mixture by Stability Indicating TLC Method
    Prajapati DJ, Chhalotiya UK, Prajapati MD, et al. · Current drug discovery technologies · 2019
  4. Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases
    Su S, Cao J, Meng X, et al. · Cancer letters · 2022 · 被引 17cited 17
  5. Discovery of a Highly Potent PROTAC Degrader of p300/CBP Proteins for the Treatment of Enzalutamide-Resistant Prostate Cancer
    Ma M, Li M, Zhang C, et al. · Journal of medicinal chemistry · 2024 · 被引 12cited 12
  6. A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer
    Meng X, Wu Q, Cao C, et al. · Journal of translational medicine · 2025 · 被引 10cited 10

合成路线文献Synthetic-route papers

  1. Synthesis of Enantiospecific Androgen Receptor Antagonists of Enzalutamide-Resistant Human Prostate Cancer Cells
    Liu C, Sun Y, Myat Thwe P, et al. · ACS medicinal chemistry letters · 2026
  2. Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis
    Wei L, Wang Z, Gao D, et al. · The Prostate · 2026
  3. Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
    Kang B, Mottamal M, Zhong Q, et al. · Pharmaceuticals (Basel, Switzerland) · 2023

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

恩扎卢胺 杂质谱研究要点Enzalutamide — impurity profiling notes

下面这些是拿到 恩扎卢胺 的 53 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 53 impurity entries for Enzalutamide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances